Prostate Cancer Reports

Volume 6 Supplement 5
September 2018


Home > Prostate Cancer Reports > Volume 6, Year 2018 > Supplement 5, September



CONTENTS


DIAGNOSIS
ETIOLOGY, PATHOGENESIS, PATHOLOGY
FOLLOW-UP, QUALITY OF LIFE
OVERALL MANAGEMENT
TREATMENT





DIAGNOSIS

.

Afaq A, Bomanji J.
Prostate-specific membrane antigen positron emission tomography in the management of recurrent prostate cancer.
Br Med Bull. 2018 Sep 29. doi: 10.1093/bmb/ldy032. [Epub ahead of print]
Source | Full text | Similar articles



.

Cheng H, Powers J, Schaffer K, Sartor O.
Practical Methods for Integrating Genetic Testing Into Clinical Practice for Advanced Prostate Cancer.
Am Soc Clin Oncol Educ Book. 2018 May 23;(38):372-381. doi: 10.1200/EDBK_205441.
Source | Book | Similar articles



.

Padhani AR, Tunariu N.
Metastasis Reporting and Data System for Prostate Cancer in Practice.
Magn Reson Imaging Clin N Am. 2018 Nov;26(4):527-542. doi: 10.1016/j.mric.2018.06.004.
Source | Full text | Similar articles



.

Petralia G, Padhani AR.
Whole-Body Magnetic Resonance Imaging in Oncology: Uses and Indications.
Magn Reson Imaging Clin N Am. 2018 Nov;26(4):495-507. doi: 10.1016/j.mric.2018.06.003. Epub 2018 Oct 10.
Source | Full text | Similar articles



.

Schiavina R, Chessa F, Borghesi M, Gaudiano C, Bianchi L, Corcioni B, Castellucci P, Ceci F, Ceravolo I, Barchetti G, Del Monte M, Campa R, Catalano C, Panebianco V, Nanni C, Fanti S, Minervini A, Porreca A, Brunocilla E.
State-of-the-art imaging techniques in the management of preoperative staging and re-staging of prostate cancer.
Int J Urol. 2018 Sep 20. doi: 10.1111/iju.13797. [Epub ahead of print]
Source | Full text | Similar articles



.

Varma M, Cochlin D, Delahunt B, Kynaston H, Rees J, Rous B, Narahari K.
TNM clinical staging of prostate cancer: Issues and solutions.
BJU Int. 2018 Oct 13. doi: 10.1111/bju.14589. [Epub ahead of print]
Source | Full text | Similar articles



ETIOLOGY, PATHOGENESIS, PATHOLOGY

.

Niu Y, Guo C, Wen S, Tian J, Luo J, Wang K, Tian H, Yeh S, Chang C.
ADT with antiandrogens in prostate cancer induces adverse effect of increasing resistance, neuroendocrine differentiation and tumor metastasis.
Cancer Lett. 2018 Sep 15;439:47-55. doi: 10.1016/j.canlet.2018.09.020. [Epub ahead of print]
Source | Full text | Similar articles



FOLLOW-UP, QUALITY OF LIFE

.

Ahmad MN, Raghavan D.
Balancing Outcomes: Focusing on Value in Treatment of Prostate Cancer.
J Oncol Pract. 2018 Oct;14(10):588-590. doi: 10.1200/JOP.18.00523.
Source | Full text | Similar articles



.

Capogrosso P, Vertosick EA, Benfante NE, Eastham JA, Scardino PJ, Vickers AJ, Mulhall JP.
Are We Improving Erectile Function Recovery After Radical Prostatectomy? Analysis of Patients Treated over the Last Decade.
Eur Urol. 2018 Sep 17. pii: S0302-2838(18)30641-9. doi: 10.1016/j.eururo.2018.08.039. [Epub ahead of print]
Source | Full text | Similar articles



.

Gupta D, Lee Chuy K, Yang JC, Bates M, Lombardo M, Steingart RM.
Cardiovascular and Metabolic Effects of Androgen-Deprivation Therapy for Prostate Cancer.
J Oncol Pract. 2018 Oct;14(10):580-587. doi: 10.1200/JOP.18.00178.
Source | Full text | Similar articles



OVERALL MANAGEMENT

.

Armstrong AJ.
Updates in advanced prostate cancer 2018.
Prostate Cancer Prostatic Dis. 2018 Oct 2. doi: 10.1038/s41391-018-0100-7. [Epub ahead of print]
Source | Full text | Similar articles



.

Bekelman JE, Rumble RB, Freedland SJ.
Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an AUA/ASTRO/SUO Guideline Summary.
J Oncol Pract. 2018 Oct;14(10):618-624. doi: 10.1200/JOP.18.00434. Epub 2018 Sep 10.
Source | Full text | Similar articles



.

Hahn AW, Higano CS, Taplin ME, Ryan CJ, Agarwal N.
Metastatic Castration-Sensitive Prostate Cancer: Optimizing Patient Selection and Treatment.
Am Soc Clin Oncol Educ Book. 2018 May 23;(38):363-371. doi: 10.1200/EDBK_200967.
Source | Book | Similar articles



.

Lecouvet FE, Oprea-Lager DE, Liu Y, Ost P, Bidaut L, Collette L, Deroose CM, Goffin K, Herrmann K, Hoekstra OS, Kramer G, Lievens Y, Lopci E, Pasquier D, Petersen LJ, Talbot JN, Zacho H, Tombal B, deSouza NM.
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group.
Lancet Oncol. 2018 Oct;19(10):e534-e545. doi: 10.1016/S1470-2045(18)30571-0. Epub 2018 Oct 1.
Source | Full text | Similar articles



.

Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, Ray M, Sandler H.
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline.
J Clin Oncol. 2018 Oct 11:JCO1801097. doi: 10.1200/JCO.18.01097. [Epub ahead of print]
Source | Full text | Similar articles



.

Pezaro CJ, Marciscano AE, Madan RA.
The Winds of Change: Emerging Therapeutics in Prostate Cancer.
Am Soc Clin Oncol Educ Book. 2018 May 23;(38):382-390. doi: 10.1200/EDBK_201295.
Source | Book | Similar articles



.

Schwen ZR, Partin AW; James Buchanan Brady Urological.
Best of the 2018 AUA Annual Meeting.
Rev Urol. 2018;20(2):98-100. doi: 10.3909/riu0806.
Source | Full text | Similar articles



.

Spratt DE.
Evidence-based Risk Stratification to Guide Hormone Therapy Use With Salvage Radiation Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):556-560. doi: 10.1016/j.ijrobp.2018.06.037.
Source | Full text | Similar articles



.

Spratt DE, McHugh DJ, Morris MJ, Morgans AK.
Management of Biochemically Recurrent Prostate Cancer: Ensuring the Right Treatment of the Right Patient at the Right Time.
Am Soc Clin Oncol Educ Book. 2018 May 23;(38):355-362. doi: 10.1200/EDBK_200319.
Source | Book | Similar articles



.

Van Calster B, Wynants L, Verbeek JFM, Verbakel JY, Christodoulou E, Vickers AJ, Roobol MJ, Steyerberg EW.
Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators.
Eur Urol. 2018 Sep 19. pii: S0302-2838(18)30640-7. doi: 10.1016/j.eururo.2018.08.038. [Epub ahead of print]
Source | Full text | Similar articles



.

Yu EY, Gillessen S, Mottet N.
What Do the Guidelines Say for Metastatic Prostate Cancer Starting Androgen Deprivation Therapy? National Comprehensive Cancer Network, European Society for Medical Oncology, and European Association of Urology recommendations.
Eur Urol Focus. 2018 Oct 1. pii: S2405-4569(18)30287-6. doi: 10.1016/j.euf.2018.09.015. [Epub ahead of print]
Source | Full text | Similar articles



TREATMENT

.

Baciarello G, Gizzi M, Fizazi K.
Advancing therapies in metastatic castration-resistant prostate cancer.
Expert Opin Pharmacother. 2018 Oct 12:1-8. doi: 10.1080/14656566.2018.1527312. [Epub ahead of print]
Source | Full text | Similar articles



.

Delporte G, Henon F, Ploussard G, Briganti A, Rizk J, Rozet F, Touijer K, Ouzzane A.
Radical prostatectomy for locally advanced and high-risk prostate cancer: A systematic review of the literature.
Prog Urol. 2018 Sep 24. pii: S1166-7087(18)30472-X. doi: 10.1016/j.purol.2018.08.007. [Epub ahead of print]
Source | Full text | Similar articles



.

Gravis G, Boher JM, Chen YH, Liu G, Fizazi K, Carducci MA, Oudard S, Joly F, Jarrard DM, Soulie M, Eisenberger MJ, Habibian M, Dreicer R, Garcia JA, Hussain MHM, Kohli M, Vogelzang NJ, Picus J, DiPaola R, Sweeney C.
Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies.
Eur Urol. 2018 Jun;73(6):847-855. doi: 10.1016/j.eururo.2018.02.001. Epub 2018 Feb 21.
Source | Full text | Similar articles



.

Hamilou Z, Baciarello G, Fizazi K.
Treatment of Castration-naive Metastatic Prostate Cancer.
Eur Urol Focus. 2017 Dec;3(6):518-521. doi: 10.1016/j.euf.2018.02.004. Epub 2018 Feb 27.
Source | Full text | Similar articles



.

Loriot Y, Supiot S, Beauval JB, Schlürmann F, Pasticier G, Sargos P, Barthélémy P, Pignot G, Maillet D, Vincendeau S, Gross E, Ploussard G, Timsit MO, Borchiellini D.
Management of non-metastatic castrate-resistant prostate cancer: A systematic review.
Cancer Treat Rev. 2018 Sep 21;70:223-231. doi: 10.1016/j.ctrv.2018.09.006. [Epub ahead of print]
Source | Full text | Similar articles



.

Sakamoto S.
Editorial Comment to ‘Local treatment for metastatic prostate cancer: A systematic review’.
Int J Urol. 2018 May;25(5):403-404. doi: 10.1111/iju.13588.
Source | Full text | Similar articles



.

Sun G, Zhang X, Chen J, Liao B, Liu Z, Zhao J, Gao AC, Yang Y, Shu K, Liu J, Zhao P, Shen P, Zeng H.
What kind of patients with castration-naïve prostate cancer can benefit from upfront docetaxel and abiraterone: A systematic review and a network meta-analysis.
Urol Oncol. 2018 Oct 10. pii: S1078-1439(18)30344-2. doi: 10.1016/j.urolonc.2018.09.005. [Epub ahead of print]
Source | Full text | Similar articles



.

Tilki D, Pompe RS, Bandini M, Marchioni M, Kretschmer A, Tian Z, Karakiewicz PI, Evans CP.
Local treatment for metastatic prostate cancer: A systematic review.
Int J Urol. 2018 May;25(5):390-403. doi: 10.1111/iju.13535. Epub 2018 Mar 23.
Source | Full text | Similar articles



.

Yano A, Kawakami S.
Re: Local treatment for metastatic prostate cancer: A systematic review.
Int J Urol. 2018 Sep 30. doi: 10.1111/iju.13809. [Epub ahead of print]
Source | Full text | Similar articles





bottom